High-dose itraconazole in the treatment of severe mycoses.
Eight patients with systemic mycoses and with prior treatment failures were treated with itraconazole (600 mg/day) for a mean duration of 5.5 months. All six patients without AIDS experienced improvement or stabilization of their fungal infections while receiving high-dose itraconazole, although two...
Збережено в:
| Опубліковано в:: | Antimicrob Agents Chemother |
|---|---|
| Автори: | , , , , , |
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
American Society for Microbiology (ASM)
1991
|
| Предмети: | |
| Онлайн доступ: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245083/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1648887/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.4.707 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
